Beacon Investment Advisory Services Inc. Sells 8,040 Shares of Danaher Co. (NYSE:DHR)

Beacon Investment Advisory Services Inc. trimmed its holdings in Danaher Co. (NYSE:DHR) by 5.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 148,907 shares of the conglomerate’s stock after selling 8,040 shares during the period. Danaher comprises about 1.5% of Beacon Investment Advisory Services Inc.’s holdings, making the stock its 17th largest position. Beacon Investment Advisory Services Inc.’s holdings in Danaher were worth $34,182,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. FMR LLC raised its position in Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after buying an additional 3,217,631 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Danaher by 17.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock valued at $996,141,000 after purchasing an additional 535,254 shares during the last quarter. International Assets Investment Management LLC lifted its position in shares of Danaher by 40,196.5% during the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock valued at $119,539,000 after purchasing an additional 428,897 shares in the last quarter. Montrusco Bolton Investments Inc. boosted its holdings in Danaher by 30.4% during the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after purchasing an additional 397,671 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec increased its stake in Danaher by 82.4% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 653,375 shares of the conglomerate’s stock valued at $181,651,000 after buying an additional 295,187 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Up 0.0 %

Shares of NYSE DHR opened at $244.19 on Thursday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The business has a 50-day moving average of $234.90 and a 200-day moving average of $253.47. The firm has a market capitalization of $176.38 billion, a price-to-earnings ratio of 46.60, a PEG ratio of 4.43 and a beta of 0.83. Danaher Co. has a 12 month low of $225.42 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the company earned $2.02 EPS. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. Sell-side analysts expect that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Robert W. Baird cut their target price on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research note on Friday, December 13th. Royal Bank of Canada lowered their target price on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Stephens reissued an “overweight” rating and issued a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Finally, Scotiabank assumed coverage on shares of Danaher in a report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $285.55.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.